| Literature DB >> 26296890 |
Gerhard Multhaup1, Otmar Huber2, Luc Buée3, Marie-Christine Galas3.
Abstract
Amyloid precursor protein (APP) metabolites (amyloid-β (Aβ) peptides) and Tau are the main components of senile plaques and neurofibrillary tangles, the two histopathological hallmarks of Alzheimer disease. Consequently, intense research has focused upon deciphering their physiological roles to understand their altered state in Alzheimer disease pathophysiology. Recently, the impact of APP metabolites (APP intracellular fragment (AICD) and Aβ) and Tau on the nucleus has emerged as an important, new topic. Here we discuss (i) how AICD, Aβ, and Tau reach the nucleus and how AICD and Aβ control protein expression at the transcriptional level, (ii) post-translational modifications of AICD, Aβ, and Tau, and (iii) what these three molecules have in common.Entities:
Keywords: Alzheimer disease; DNA-protein interaction; Tau protein (Tau); amyloid precursor protein (APP); amyloid-beta (AB); gene regulation; gene transcription
Mesh:
Substances:
Year: 2015 PMID: 26296890 PMCID: PMC4583011 DOI: 10.1074/jbc.R115.677211
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157